Get the Stockscreener App
153.10
2.03%
3.04
After Hours:
153.70
0.60
+0.39%
Twist Bioscience Corp stock is traded at $153.10, with a volume of 1.25M.
It is up +2.03% in the last 24 hours and up +76.91% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$150.06
Open:
$149.23
24h Volume:
1.25M
Relative Volume:
0.70
Market Cap:
$9.60B
Revenue:
$409.48M
Net Income/Loss:
$-81.28M
P/E Ratio:
-115.23
EPS:
-1.3286
Net Cash Flow:
$-95.14M
1W Performance:
+12.30%
1M Performance:
+76.91%
6M Performance:
+226.30%
1Y Performance:
+463.07%
1-Day Range:
$148.44
$155.44
1-Week Range:
$135.05
$155.44
52-Week Range:
$23.30
$155.44
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
153.10 | 8.55B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media
Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade
Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan
Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan
Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com
Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat
Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada
Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com
Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart
Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com
Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan
Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga
Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com
Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan
Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative
TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus
Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget
Twist Bioscience (NASDAQ:TWST) Hits New 52-Week HighShould You Buy? - MarketBeat
Why is Twist Bioscience stock surging today? - Investing.com
Why is Twist Bioscience stock surging today? By Investing.com - Investing.com Canada
Twist Bioscience Selected as Independent Evaluator in Anthropic's AI-Driven Protein Design Initiative - Kalkine Media
Form 8K Twist Bioscience Corp For: 19 August By Investing.com - Investing.com Nigeria
Twist Bioscience selected as evaluator for Anthropic AI protein design project - Investing.com
Anthropic selects Twist Bioscience as independent evaluator for AI-designed protein testing - TradingView
Twist Bioscience (NASDAQ: TWST) insider plans multimillion-dollar stock sale - Stock Titan
A Look at Twist Bioscience Corp (TWST) After 5.0% Gain -- GF Val - GuruFocus
Twist Bioscience (TWST) Is Down 5.1% After Upsized Equity Raise And Guidance Hike Has The Bull Case Changed? - simplywall.st
Bank of America Corp DE Grows Stake in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience CEO Emily Leproust Executes Sale of 19,952 Shares via 10b5-1 Plan - Kalkine Media
Twist Bioscience Corp (TWST) Stock Down 5.4% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Director Katryn Blake Executes Sell-to-Cover of 2,240 Shares for RSU Tax Obligations - Kalkine Media
Twist Bioscience (TWST) director sells 2,240 shares to cover RSU tax - Stock Titan
Twist Bioscience (TWST): ARK Investment Management reports 4.55M-share, 7.31% stake - Stock Titan
Twist Bioscience (NASDAQ:TWST) Trading Down 4.3%Here's What Happened - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan
Twist Bioscience (TWST): EdgePoint discloses 4.21% beneficial stake in amended 13G - Stock Titan
Artisan Partners group (TWST) discloses 4.8M-share position in Twist Bioscience - Stock Titan
Twist Bioscience stock hits 52-week high at 126.22 USD By Investing.com - Investing.com Australia
Twist Bioscience stock hits 52-week high at 126.22 USD - Investing.com
Twist Bioscience CEO Emily Leproust Executes Stock Option Exercise and Sells 113,318 Shares Under 10b5-1 Plan - Kalkine Media
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells $14,182,880.88 in Stock - MarketBeat
Twist Bioscience (TWST) insider Leproust plans resale after option exercise - Stock Titan
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):